Doctors Note Logo

Published on: 4/24/2026

Energy Boost: Using RLT to Manage Multiple Sclerosis Fatigue

Red light therapy uses specific wavelengths of red and near infrared light to boost cellular energy, reduce inflammation and support muscle performance, showing promise as a complementary approach for easing MS-related fatigue and mobility challenges in early studies and related trials.

There are several factors to consider, including device specifications, treatment frequency, safety precautions and how to integrate RLT into a broader MS management plan, so see below for more important details.

answer background

Explanation

Energy Boost: Using Red Light Therapy for MS Fatigue and Mobility

Multiple sclerosis (MS) often brings persistent fatigue and reduced mobility, affecting daily life and quality of life. Red light therapy (RLT) has emerged as a potential complementary approach to ease these challenges. Below, we'll explore what RLT is, how it may help MS-related fatigue and mobility issues, the scientific backing, practical guidelines, and important safety considerations.

What Is Red Light Therapy?

Red light therapy (also called low-level laser therapy or photobiomodulation) uses specific wavelengths of red and near-infrared light (600–1,000 nm) to stimulate cellular processes. Unlike ultraviolet light, RLT is non-thermal and non-invasive. Key proposed mechanisms include:

  • Enhanced mitochondrial function and increased ATP (cellular energy) production
  • Improved microcirculation and oxygen delivery to tissues
  • Reduced oxidative stress and inflammation
  • Promotion of cellular repair and regeneration

Why MS Fatigue and Mobility Matter

Fatigue in MS is more than just feeling tired—it's an overwhelming sense of exhaustion that can strike suddenly and interfere with concentration, mood, and physical activity. Mobility issues (muscle weakness, spasticity, balance problems) often go hand-in-hand, making simple tasks feel daunting.

  • Up to 80 percent of people with MS report significant fatigue.
  • Fatigue is a top contributor to reduced work hours and social participation.
  • Mobility limitations increase the risk of falls, muscle atrophy, and further fatigue.

By targeting energy production and inflammation, RLT may offer relief for both fatigue and mobility challenges.

What the Research Says

While research specifically in MS is still growing, early studies and related trials provide promising insights:

  1. Mitochondrial Support

    • Small studies show RLT can boost mitochondrial respiration and ATP levels in muscle cells, potentially counteracting MS-related energy deficits.
  2. Inflammation Reduction

    • Photobiomodulation reduces pro-inflammatory cytokines (IL-1β, TNF-α) in animal models of neuroinflammation.
    • Lowering inflammation may ease central fatigue and support nerve health.
  3. Muscle Performance

    • In non-MS populations, RLT pre-exercise improved muscle strength, reduced soreness, and accelerated recovery—suggesting potential benefits for MS-related muscle weakness and post-activity fatigue.
  4. Neuroprotection

    • Early-stage clinical trials hint at neuroprotective effects in central nervous system injuries. While direct MS trials are limited, these findings support further research.

Practical Guide to Using RLT

If you're considering RLT for MS fatigue and mobility, follow these practical steps:

1. Choose the Right Device

  • Wavelengths: Aim for 630–670 nm (red) and 800–880 nm (near-infrared).
  • Power Output: Look for devices delivering 20–200 mW/cm². Home-use panels often provide 30–60 mW/cm².
  • Size: Handheld units for localized spots; larger panels for whole-body or multiple muscle groups.

2. Establish a Treatment Protocol

  • Frequency: Start with 3–5 times per week.
  • Duration: 10–20 minutes per area per session.
  • Distance: Place the device 6–12 inches from the skin (follow manufacturer guidelines).
  • Areas to Target:
    • Major muscle groups (thighs, calves, shoulders) to boost strength.
    • Spine and neck regions to address central nervous system pathways.
    • Hands and feet if mobility is limited in extremities.

3. Track Your Progress

  • Keep a daily log of:
    • Fatigue levels (use a 0–10 scale).
    • Mobility milestones (walking distance, ease of transfers).
    • Any side effects (skin warmth, mild redness).
  • Adjust your protocol based on improvements or plateaus.

Potential Benefits

While individual responses vary, many users report:

  • Increased daily energy and reduced mid-day crashes
  • Enhanced muscle strength and endurance
  • Less muscle soreness and quicker recovery after activity
  • Improved mood and mental clarity
  • Gradual gains in walking distance and balance

Safety and Side Effects

RLT is generally safe when used as directed, but keep in mind:

  • Possible Mild Reactions: Temporary skin redness or warmth at the treatment site.
  • Eye Protection: Avoid staring directly at the light. Use goggles if recommended.
  • Device Quality: Choose FDA-cleared or CE-marked devices to ensure proper output and safety standards.
  • Interactions: RLT is non-drug, so it typically doesn't interfere with medications, but always confirm with your healthcare provider.

Integrating RLT into a Broader MS Management Plan

RLT works best as one component in a comprehensive approach:

  • Exercise and Physical Therapy

    • Low-impact aerobics (swimming, cycling) boosts cardiovascular health.
    • Stretching and balance exercises reduce spasticity and fall risk.
  • Nutrition and Hydration

    • Anti-inflammatory diet (rich in omega-3s, antioxidants).
    • Adequate protein to support muscle repair.
  • Sleep and Stress Management

    • Prioritize sleep hygiene (consistent schedule, dark cool room).
    • Mindfulness or gentle yoga to ease mental fatigue.
  • Medical Treatments

    • Disease-modifying therapies (DMTs) as prescribed.
    • Symptom-specific medications (for spasticity, pain, sleep).

Setting Realistic Expectations

  • Timeline: Some people feel subtle changes within 2–4 weeks; significant improvements may take 2–3 months.
  • Variability: Results depend on MS type, fatigue severity, and overall health.
  • Complementarity: RLT is supportive, not curative. It's best combined with other lifestyle and medical strategies.

When to Reconsider or Halt Therapy

  • New or worsening neurological symptoms (vision changes, severe weakness)
  • Skin burns or persistent irritation
  • No improvement after 8–12 weeks of consistent use

If you experience any serious or life-threatening symptoms, stop therapy immediately and seek medical attention.

Next Steps

If you're experiencing fatigue, mobility challenges, or other concerning symptoms and want to better understand whether they could be related to Multiple Sclerosis (MS), take a free AI-powered symptom assessment to help determine your next steps and when to seek medical care.

Always discuss any new therapy—including red light therapy for MS fatigue and mobility—with your neurologist or primary care provider. They can help tailor your treatment plan, monitor progress, and ensure your safety.


Disclaimer: This information is educational and not a substitute for professional medical advice. Speak to a doctor about any symptoms that could be life-threatening or serious.

(References)

  • * Srivastava V, Agrawal S, Pal Singh G, Das L, Bapna P, Srivastava M. The Use of Photobiomodulation for Fatigue in Multiple Sclerosis: A Narrative Review. *J Lasers Med Sci.* 2023 Spring;14:e17. doi: 10.34172/jlms.2023.17. PMID: 37077553.

  • * Saeidian T, Zoghi-Esfahani E, Kazemi M, Dehghan Manshadi S, Ramezani F. Photobiomodulation and Exercise in Multiple Sclerosis Patients: A Pilot Clinical Trial. *J Lasers Med Sci.* 2022 Spring;13:e23. doi: 10.34172/jlms.2022.23. PMID: 35165620.

  • * Salehpour F, Ramezani F, Ahmadi S, Mirzai F, Salehpour S, Karami G, Mahmodi M, Sabeti M, Gholampour Z, Sabeti M, Sadeghi A, Gholampour A, Mahmoudi M, Rasti H, Salehpour M. Therapeutic efficacy of red and near-infrared light on symptoms and markers of oxidative stress and inflammation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial. *Photochem Photobiol Sci.* 2023 Dec 11;23(1):21-34. doi: 10.1007/s43630-023-00508-2. PMID: 37996504.

  • * Torkaman-Zadeh H, Mehrabani M, Vafaei M, Kazemi F. Transcranial photobiomodulation in multiple sclerosis: a comprehensive review of mechanisms and clinical applications. *Lasers Med Sci.* 2023 Jul 21;38(1):164. doi: 10.1007/s10103-023-03823-y. PMID: 37299099.

  • * Pajović G, Marić D, Srzentić R, Bjelica A. Low-level laser therapy for the treatment of fatigue in multiple sclerosis: a systematic review. *Lasers Med Sci.* 2024 Feb 5;39(1):97. doi: 10.1007/s10103-024-04020-w. PMID: 38318712.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.